Auricular Acupuncture in Postoperative Pain
2 other identifiers
interventional
40
1 country
1
Brief Summary
The effect of acupuncture for postoperative pain control remains controversial. We therefore studied the effects of electrical auricular acupuncture (AA) on postoperative opioid consumption in a randomized, patient-blinded clinical trial. 40 female patients undergoing laparoscopy were included. Anaesthetized patients were randomly assigned to receive AA (shen men, thalamus and one segmental organ-specific point) or electrodes and electrical stimulation for 72 hours. Postoperatively patients received 1 g paracetamol every 6 hours and additional piritramide on demand. A blinded observer obtained the doses of piritramide and the visual analogue pain scores (VAS) at 0, 2, 24, 48, and 72 hours. It was the aim of our study to find out, whether auricular acupuncture reduces postoperative pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Jan 2006
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 9, 2009
CompletedFirst Posted
Study publicly available on registry
December 10, 2009
CompletedApril 8, 2015
January 1, 2006
1.9 years
December 9, 2009
April 7, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
mean postoperative pain (VAS score)
0,2,24,48,72 hours
Secondary Outcomes (1)
consumption of piritramide postoperatively
0,2,24,48,72 hours postoperatively
Study Arms (2)
electrical auricular acupuncture
ACTIVE COMPARATORPatients in the acupuncture group received titan disposable needles (27-gauge, 3 mm length; Biegler GmbH, Mauerbach, Austria), which were inserted in the dominant ear at the following acupuncture points: shen men, thalamus and one segmental organ-specific point. Acupuncture points were identified by measuring skin resistance, using an electrical conductance meter (multipoint selection pen™, Biegler GmbH, Mauerbach, Austria). The needles were connected to the P-Stim™ device and received continuous low frequency electro acupuncture using P-Stim™ (constant current: 1 Hz biphasic, 2 mA) for 72 hours postoperatively. Acupuncture was performed by a specialist with 15 years experience in this technique.
pstim device without acupuncture
PLACEBO COMPARATORPatients in the control group received electrodes without needles and the P-Stim™ devices were applied without electrical stimulation.
Interventions
Patients in the acupuncture group received titan disposable needles (27-gauge, 3 mm length; Biegler GmbH, Mauerbach, Austria), which were inserted in the dominant ear at the following acupuncture points: shen men, thalamus and one segmental organ-specific point \[2\]. Acupuncture points were identified by measuring skin resistance, using an electrical conductance meter (multipoint selection pen™, Biegler GmbH, Mauerbach, Austria). The needles were connected to the P-Stim™ device and received continuous low frequency electro acupuncture using P-Stim™ (constant current: 1 Hz biphasic, 2 mA) for 72 hours postoperatively. Acupuncture was performed by a specialist with 15 years experience in this technique.
Patients in the control group received electrodes without needles and the P-Stim™ devices were applied without electrical stimulation.
Eligibility Criteria
You may qualify if:
- female ASA physical status I-III patients undergoing elective gynaecological laparoscopy
- (surgery in cases of infertility, ovarian cyst removal, adhesiolysis, adnexal surgery,endometriosis, or hysterectomy),
- aged from 18-60 years.
You may not qualify if:
- patients with a history of drug abuse,
- regular use of sedatives,
- chronic analgesic medication,
- neurological or psychiatric diseases,
- adverse reaction to sevoflurane or paracetamol,
- ASA physical status \> III,
- pacemaker, or a history of acupuncture treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University Vienna
Vienna, 1090, Austria
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea Holzer, MD
Medical University Vienna, Department of Anesthesiology and General Intensive Care Medicine
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 9, 2009
First Posted
December 10, 2009
Study Start
January 1, 2006
Primary Completion
December 1, 2007
Study Completion
February 1, 2008
Last Updated
April 8, 2015
Record last verified: 2006-01